BR9810452A - New combination of asthma drugs - Google Patents

New combination of asthma drugs

Info

Publication number
BR9810452A
BR9810452A BR9810452-7A BR9810452A BR9810452A BR 9810452 A BR9810452 A BR 9810452A BR 9810452 A BR9810452 A BR 9810452A BR 9810452 A BR9810452 A BR 9810452A
Authority
BR
Brazil
Prior art keywords
new combination
asthma drugs
presenting
kit
composition
Prior art date
Application number
BR9810452-7A
Other languages
Portuguese (pt)
Inventor
Axelsson Bengt
Leif Kollstroem
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9810452A publication Critical patent/BR9810452A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Abstract

<B>"NOVA COMBINAçãO DE MEDICAMENTOS CONTRA ASMA"<D>. A invenção fornece uma composição ou um kit, apresentando como um primeiro ingrediente ativo formoterol ou um sal ou solvato derivado do mesmo e apresentando como um segundo ingrediente ativo roplefonida ou um éster de ácido graxo do mesmo. São também divulgados métodos de tratamento de doenças respiratórias usando essa composição ou esse kit.<B> "NEW COMBINATION OF DRUGS AGAINST ASTHMA" <D>. The invention provides a composition or a kit, presenting as a first active ingredient formoterol or a salt or solvate derived therefrom and presenting as a second active ingredient roplefonide or a fatty acid ester thereof. Methods of treating respiratory diseases using this composition or kit are also disclosed.

BR9810452-7A 1997-06-27 1998-06-08 New combination of asthma drugs BR9810452A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88382397A 1997-06-27 1997-06-27
PCT/SE1998/001089 WO1999000134A1 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments

Publications (1)

Publication Number Publication Date
BR9810452A true BR9810452A (en) 2000-09-05

Family

ID=25383399

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810452-7A BR9810452A (en) 1997-06-27 1998-06-08 New combination of asthma drugs

Country Status (16)

Country Link
EP (1) EP1009408A1 (en)
JP (1) JP2002510310A (en)
KR (1) KR20010014162A (en)
AU (1) AU8135098A (en)
BR (1) BR9810452A (en)
CA (1) CA2295076A1 (en)
EE (1) EE9900594A (en)
HU (1) HUP0002533A3 (en)
ID (1) ID24063A (en)
IL (1) IL133597A0 (en)
IS (1) IS5303A (en)
NO (1) NO996438L (en)
PL (1) PL337722A1 (en)
SK (1) SK184799A3 (en)
TR (1) TR199903272T2 (en)
WO (1) WO1999000134A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (en) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (en) 1998-06-11 1998-06-11 Astra Ab New use
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
SE9900833D0 (en) * 1999-03-09 1999-03-09 Astra Ab Novel combination
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0009617D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2004028545A1 (en) * 2002-09-25 2004-04-08 Astrazeneca Ab A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (en) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
HU0004452D0 (en) * 1991-12-18 2001-01-29 Astra Ab
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation
SE9501384D0 (en) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
SE9603669D0 (en) * 1996-10-08 1996-10-08 Astra Ab New combination

Also Published As

Publication number Publication date
WO1999000134A1 (en) 1999-01-07
CA2295076A1 (en) 1999-01-07
HUP0002533A3 (en) 2001-03-28
IS5303A (en) 1999-12-15
KR20010014162A (en) 2001-02-26
NO996438D0 (en) 1999-12-23
EP1009408A1 (en) 2000-06-21
NO996438L (en) 2000-02-28
ID24063A (en) 2000-07-06
HUP0002533A2 (en) 2000-12-28
SK184799A3 (en) 2000-06-12
JP2002510310A (en) 2002-04-02
EE9900594A (en) 2000-08-15
IL133597A0 (en) 2001-04-30
PL337722A1 (en) 2000-08-28
AU8135098A (en) 1999-01-19
TR199903272T2 (en) 2000-08-21

Similar Documents

Publication Publication Date Title
FR2714830B1 (en) Composition containing nucleic acids, preparation and uses.
SE0001899D0 (en) New compounds
AU2845599A (en) Pharmaceutical compositions and their use
EA200001125A1 (en) PHARMACEUTICAL PHARMACEUTICAL COMPOSITIONS
BR9905977A (en) Ccr5 modulators
BR0317747A (en) Method of concomitant therapeutic treatment of an individual, pharmaceutical composition, kit, use of a first agent and a second agent, and methods of preventing or treating amyloid-b-related disease, alzheimer&#39;s disease and mild cognitive impairment
YU40701A (en) Piperidines as ccr5 modulators
BR9908280A (en) Phospholipase enzyme inhibitors
HUP0104718A2 (en) Micronized eplerenone compositions and process for their preparation
BR0212897A (en) Diagnostic or therapeutic somatostatin or bombesin analogues conjugates and uses thereof
ATE314092T1 (en) BIOLOGICAL ADHESIVES AND METHOD FOR THE TOPICAL ADMINISTRATION OF ACTIVE INGREDIENTS
AU3368497A (en) Human dnase i hyperactive variants
BR9611802A (en) Pharmaceutical compositions
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
ATE267798T1 (en) COMBINED ACTIVE INGREDIENTS AS A METHOD FOR TARGETED ACTIVE RELEASE
BG103552A (en) Therapeutical forms
HUP0004396A2 (en) Pharmaceutical compositions containing hydroxylated cholesterol lowering agent as inhibitor of lipoprotein oxidation
ES2163034T3 (en) MICELLARY COMPOSITIONS OF POLYETER BLOCK COPOLYMERS, FOR THE OBJECTIVATION OF BIOLOGICAL AGENTS AS DIANA.
BR9810312A (en) Pharmaceutical composition that has marked antitumor activity and / or reduced side effects containing an antitumor agent and a derivative of hydroxy acid
PT918517E (en) COMPOSITION OF MICRO-ORGANISMS CONTAINING FATTY ACIDS OMEGA-3 UTIL AS A PROPRIETARY OR THERAPEUTIC AGENT AGAINST COCIDIOSIS OF ANIMALS
BR0318278A (en) aminocyclohexyl ether compounds and uses thereof
ATE322570T1 (en) COMPOSITION AGAINST ODOR OF SWEAT AND PROCESS OF USE
BR9810452A (en) New combination of asthma drugs
PT1050301E (en) Medicinal compositions containing 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
BR9916575A (en) Pharmaceutical composition of controlled release with tilidine mesylate as active substance

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A,5A,6A,7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.